Clinical and Serologic Responses After a Two-Dose Series of High-Dose Influenza Vaccine in Plasma Cell Disorders: A Prospective, Single-Arm Trial
Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2017.02.025
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2017
Authors
Publisher
Elsevier BV